Genprex In Licenses Additional Gene Therapy Technologies For Treatment Of Lung Cancer

Genprex In Licenses Additional Gene Therapy Technologies For Treatment Of Lung Cancer

By, Admin 8 May 2021

Genprex, Inc., A Clinical-Stage Gene Therapy Company Focused On Developing Life-Changing Technologies For Patients With Cancer And Diabetes, Today Announced That The Company And A Major Cancer Research Center In Houston, Texas, In March 2021, Entered Into An Amendment (The &Ldquo;Amendment&Rdquo;) To Their May 2020 License Agreement (The &Ldquo;License Agreement&Rdquo;) To Grant To Genprex An Exclusive Worldwide License To An Additional Portfolio Of Six Patents And One Patent Application And Related Technology (&Ldquo;Newly Licensed Ip&Rdquo;). The Newly Licensed Ip Includes Methods For Treating Non-Small Cell Lung Cancer (Nsclc) By Administration Of A Tusc2 Therapeutic In Conjunction With Egfr Inhibitors Or Other Anti-Cancer Therapies, In Patients Who Are Predicted To Be Responsive To Tusc2 Therapy. A Tusc2 Gene-Expressing Plasmid Is The Active Agent In Reqorsa&Trade; Immunogene Therapy, Genprex&Rsquo;S Lead Drug Candidate.&Ldquo;We Are Pleased To Continue Optimizing And Expanding Our World-Class Intellectual Property Portfolio With The Addition Of These Technologies,&Rdquo; Said Rodney Varner, President And Chief Executive Officer Of Genprex. &Ldquo;These New Technologies Further Add To Our Arsenal Of Combination Therapies For Reqorsa, And May Enable Us To Improve Patient Outcomes Through The Advancement Of Multiple Therapeutic Approaches.&Rdquo;

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!